Ai-Hong Ma

Title: Innovations in Cancer Treatment by Ai-Hong Ma

Introduction

Ai-Hong Ma is a notable inventor based in Sacramento, CA, who has made significant contributions to the field of cancer treatment. His innovative approaches focus on improving the efficacy of chemotherapy while minimizing adverse side effects. With a patent portfolio that includes groundbreaking methods, Ai-Hong Ma is recognized for his dedication to enhancing patient care.

Latest Patents

Ai-Hong Ma holds a patent for "Methods of improving cancer chemotherapy." This patent outlines methods and compositions designed to prolong survival and reduce or inhibit tumor growth in cancer patients undergoing chemotherapy. The invention incorporates the use of an inhibitor of soluble epoxide hydrolase (sEHi) and a non-steroidal anti-inflammatory drug (NSAID) that targets specific enzymes, thereby decreasing toxicity and adverse side effects associated with chemotherapy regimens.

Career Highlights

Throughout his career, Ai-Hong Ma has worked with prestigious institutions, including the University of California and the United States Government as represented by the Department of Veterans Affairs. His work has been instrumental in advancing cancer treatment methodologies and improving patient outcomes.

Collaborations

Ai-Hong Ma has collaborated with esteemed colleagues, including Sung Hee Hwang and Chong-Xian Pan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of better cancer therapies.

Conclusion

Ai-Hong Ma's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving the lives of patients. His work exemplifies the importance of research and collaboration in the field of medical science.